Medical Laboratories federal obligations in FY2026
$185,921,225.04 is the USAspending.gov obligation sum for Medical Laboratories (NAICS 621511) in FY2026. About nine percent of a $2.18 billion medical-lab extract sits on FY2026. Labs are not general hospitals (622110) and not residual outpatient centers (621498). That pair is Medical Laboratories (NAICS 621511) and federal fiscal year 2026 — not every federal dollar in FY2026, not Medical Laboratories's $2,178,881,667.33 extract-wide book, and not cash already paid. The cell is 8.5% of this industry's published obligation total. 5,517 is the industry-extract award-record count, not a FY2026-only instrument tally. USAspending.gov is the source. Correlation is not causation.
Key figures
- Medical Laboratories in FY2026: $185,921,225.04 in USAspending obligations (NAICS 621511).
- That cell is 8.5% of the industry's $2,178,881,667.33 extract-wide total.
- 5,517 is the industry-extract award-record count, not a FY2026 census.
- NAICS 621511 × FY2026 is an obligation join, not an outlay and not a named-recipient list.
- Cite USAspending.gov; quote /industries/621511/ and /fiscal-years/2026/ if live tables moved.
Medical Laboratories and FY2026 as a USAspending pair
NAICS 621511 and fiscal year 2026 meet here. $185,921,225.04 is the USAspending.gov obligation sum on the yearlyTrend row that carries both tags. It is not Medical Laboratories's nationwide all-year total of $2,178,881,667.33, not every federal dollar coded to FY2026, and not an outlay register. The packet does not split diagnostic from other medical-lab lines, or contract from assistance. 5,517 is an industry-extract action count: modifications and repeat awards add rows across years. Unique recipients are unpublished. This cell is not a lab census, a named-operator roster, or a test-volume ledger.
This page reports medical laboratories activity USAspending tagged to FY2026. The headline $185,921,225.04 sits beside an industry-wide obligation total of $2,178,881,667.33; the 8.5% share is arithmetic on those two packet facts, not a ranking of fiscal years as winners or losers. Obligations are not outlays. Named operators and test counts are unpublished. Quote NAICS 621511 and FY2026 together.
How USAspending labels Medical Laboratories in FY2026
USAspending labels NAICS 621511 as Medical Laboratories. That code produced $185,921,225.04 when crossed with fiscal year 2026. The industry-wide 621511 hub does not require a FY2026 filter. The year hub does not require Medical Laboratories. Only this tie applies both filters. The packet does not split diagnostic from other medical-lab lines, or contract from assistance. FY2026 incompleteness applies. Do not treat this row as a closed test-year book.
Correlation is not causation: FY2026 did not cause $185,921,225.04 by existing as a large or small budget year. The join is 621511 × FY2026 only. This cell is not a lab census, a named-operator roster, or a test-volume ledger. Do not invent contractors or award recipients to fill the gap. Campaign donations on FEC tables do not fund this USAspending cell; the datasets are separate. Five thousand five hundred seventeen industry-extract award records describe 621511 across years, not a FY2026 lab or test-volume census.
Award records on NAICS 621511 versus the FY2026 dollar cell
5,517 is the Medical Laboratories award-record count published with the industry extract, not a count of FY2026 instruments. Dividing $185,921,225.04 by 5,517 would mix a one-year dollar total with a multi-year row count, so this page does not publish that ratio as a typical invoice. Unique recipients are unpublished. Modifications and multi-year vehicles can add lines without adding vendors. Five thousand five hundred seventeen industry-extract award records describe 621511 across years, not a FY2026 lab or test-volume census. FY2026 figures can be incomplete for the current year, so even the dollar cell may still move.
A thick parent file makes a program split tempting; the packet still does not supply one. A thin parent file makes a named-facility story tempting; the packet still does not name facilities or contractors. 8.5% of $2,178,881,667.33 is the year share on this packet, not a performance score.
Commitment totals versus cash paid
USAspending.gov records an obligation when the federal government commits funds on an award. $185,921,225.04 is that kind of sum for Medical Laboratories in FY2026. Later deobligations, recoveries, or payment schedules can change what leaves the Treasury without this join rewriting itself into a cash register. Assistance and contract awards can share the same NAICS rollup; this packet does not split them. Net obligations can include downward adjustments. This page reports $185,921,225.04 as given.
Keeping both sides of the 621511 × FY2026 pair
Cite USAspending.gov: Medical Laboratories (NAICS 621511) obligated $185,921,225.04 in FY2026. Name Medical Laboratories and FY2026 together. Keep the obligation word. If /industries/621511/ or /fiscal-years/2026/ has refreshed, prefer the live hub over this snapshot for current rows. The pair is not a lab census, a named-operator roster, or a test-volume ledger. 8.5% of $2,178,881,667.33 is the industry share on this packet, not a budget score. /industries/ lists other industries; /ties/ indexes other pairs.
Share, extract count, and what they are not
Five thousand five hundred seventeen industry-extract award records describe 621511 across years, not a FY2026 lab or test-volume census. Keep medical laboratories on FY2026. Ambulance services (621910) in this harvest are a different health key. A reader who quotes 5,517 as unique companies in FY2026 has left the packet. A reader who treats 8.5% as a hardship or success ranking has added a score the table does not carry. Prefer /industries/621511/ and /fiscal-years/2026/ if the live tables moved. Named operators and test counts are unpublished. Quote NAICS 621511 and FY2026 together.
This snapshot holds $185,921,225.04 on the yearlyTrend row and 5,517 on the industry extract. /ties/ is the index, not an addend. Obligations are not outlays. Correlation is not causation. A reader who only quotes $185,921,225.04 without FY2026 and NAICS 621511 has dropped a join side.
Questions
- How much Medical Laboratories spending is obligated in FY2026?
- USAspending.gov lists $185,921,225.04 in Medical Laboratories (NAICS 621511) obligations for FY2026. That yearlyTrend amount is 8.5% of the industry's $2,178,881,667.33 extract-wide total. It is an obligation join, not an outlay and not every federal dollar in FY2026. Unique recipients are unpublished.
- Is $185,921,225.04 the entire Medical Laboratories USAspending total?
- No. NAICS 621511's extract-wide total is $2,178,881,667.33. FY2026 is 8.5% of that book. Other fiscal-year rows for the same industry are separate cells. Do not add /industries/621511/ into this join. 5,517 award records stay on the industry extract, not on this yearlyTrend row.
- Is $185,921,225.04 cash already paid in FY2026?
- No. Obligations are commitments recorded on USAspending.gov awards. Outlays — money that actually left the Treasury — are a different concept and are not this packet's headline. Treating $185,921,225.04 as checks already cleared in FY2026 confuses those terms. Prefer the live industry and year hubs if the tables moved.
- Is $185,921,225.04 the nationwide Medical Laboratories total?
- No. $185,921,225.04 is the FY2026 yearlyTrend slice of NAICS 621511 only. Industry-wide Medical Laboratories is $2,178,881,667.33 on /industries/621511/ without this year filter. 8.5% describes this join. Outlays are unpublished. Source is USAspending.gov. USAspending.gov remains the source for NAICS 621511 in FY2026.
USAspending.gov NAICS yearlyTrend by fiscal year. Obligations are not outlays. FY figures can be incomplete for the current year.